Moderna Forecast, price target & analysts
Moderna Target price 2025 - Analyst rating & recommendation
Moderna Classifications & Recommendation:
Moderna Price Target
| Target Price | $32.13 |
| Price | $27.16 |
| Potential |
18.30%
register free of charge
|
| Number of Estimates | 24 |
|
24 Analysts have issued a price target Moderna 2026 .
The average Moderna target price is $32.13.
This is
18.30%
register free of charge
$207.90
665.46%
register free of charge
$20.20
25.63%
register free of charge
|
|
| A rating was issued by 31 analysts: 4 Analysts recommend Moderna to buy, 20 to hold and 7 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Moderna stock has an average upside potential 2026 of
18.30%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 3.24 | 2.14 |
| 52.75% | 34.02% | |
| EBITDA Margin | -100.77% | -187.36% |
| 386.66% | 85.92% | |
| Net Margin | -110.04% | -187.41% |
| 59.86% | 70.31% |
28 Analysts have issued a sales forecast Moderna 2025 . The average Moderna sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Moderna EBITDA forecast 2025. The average Moderna EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
29 Moderna Analysts have issued a net profit forecast 2025. The average Moderna net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -9.27 | -10.34 |
| 24.88% | 11.54% | |
| P/E | negative | |
| EV/Sales | 2.15 |
29 Analysts have issued a Moderna forecast for earnings per share. The average Moderna EPS is
This results in the following potential growth metrics and future valuations:
Current Moderna Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | May 22 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | May 02 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | May 02 2025 |
| UBS |
Locked
➜
Locked
|
Locked | May 02 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | May 02 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Mar 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
May 22 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
May 02 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
May 02 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
May 02 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
May 02 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Mar 21 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
